ArticleNeurology international2024

Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study.

Marcello Moccia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.